Pembrolizumab + Paclitaxel +/- Bevacizumab for Triple-negative Breast Cancer

Name: Pembrolizumab + Paclitaxel +/- Bevacizumab for Triple-negative Breast Cancer
License: Public Domain

Yukinori Ozaki

ClinicalTrials.gov · Datasets · License: Public Domain

recurrent triple-negative breast cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 245507
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.